Destiny Pharma PLC (LSE:DEST) - Share price


Stock Report

Destiny Pharma PLC DEST

Latest Morningstar Commentary
DateAuthor Headline

Latest Company News

DateTimeSourceHeadlineType
Previous Stories...
15/11/201907:30LSEPresentation at the Investival ShowcaseNRA
06/11/201907:00LSEDestiny Pharma to present at World AMR CongressNRA
16/10/201907:00LSEPositive phase 1 results published in journalNRA
23/09/201907:00LSEDirectorate ChangeBOA
23/09/201907:00LSEInterim Results for 6 months ended 30 June 2019IR
12/09/201907:00LSENotice of ResultsNOR
10/09/201907:00LSEUniversity of Sheffield Research CollaborationNRA
02/09/201907:00LSEXF Drug platform data presented at EuroBiofilmsNRA
15/08/201912:20LSEHolding(s) in CompanyHOL
31/07/201907:00LSEPresentation at Gordon Research ConferenceNRA
19/07/201915:12LSEHolding(s) in CompanyHOL
04/06/201914:39LSEGrant of OptionsDSH
04/06/201912:06LSEResult of AGMRAG
09/05/201914:06LSEAppointment of NOMAD and Joint BrokerAPP
29/04/201914:28LSEPosting of Annual Report and Notice of AGMMSC
09/04/201907:00LSEFinal ResultsFR
05/04/201917:06LSEExercise of OptionsIOE
01/04/201915:03LSEExercise of OptionsIOE
28/03/201918:13LSEExercise of OptionsIOE
27/03/201907:00LSEMedPharm to develop new XF-drug formulationsNRA
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.